Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
hypoxia-inducible factor 1 alpha subunit | 5 | 0 | 0 | 5 |
RAR-related orphan receptor gamma | 8 | 0 | 0 | 8 |
GLI family zinc finger 3 | 8 | 0 | 0 | 8 |
AR protein | 12 | 0 | 0 | 12 |
aldehyde dehydrogenase 1 family, member A1 | 4 | 0 | 0 | 4 |
retinoic acid nuclear receptor alpha variant 1 | 7 | 0 | 0 | 7 |
retinoid X nuclear receptor alpha | 8 | 0 | 0 | 8 |
estrogen nuclear receptor alpha | 12 | 0 | 0 | 12 |
peroxisome proliferator-activated receptor delta | 5 | 0 | 0 | 5 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 7 | 0 | 0 | 7 |
activating transcription factor 6 | 4 | 0 | 0 | 4 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 7 | 0 | 0 | 7 |
Histone H2A.x | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform a | 3 | 0 | 0 | 3 |
heat shock protein beta-1 | 3 | 0 | 0 | 3 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 7 | 0 | 0 | 7 |
lamin isoform A-delta10 | 8 | 0 | 0 | 8 |
Voltage-dependent calcium channel gamma-2 subunit | 5 | 0 | 0 | 5 |
Glutamate receptor 2 | 5 | 0 | 0 | 5 |
dopamine D1 receptor | 3 | 0 | 0 | 3 |
thioredoxin reductase | 5 | 0 | 0 | 5 |
GLS protein | 6 | 0 | 0 | 6 |
Thrombopoietin | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 5 | 0 | 0 | 5 |
cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
cytochrome P450 2C19 precursor | 4 | 0 | 0 | 4 |
ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
histone acetyltransferase KAT2A isoform 1 | 4 | 0 | 0 | 4 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 2 |
Spike glycoprotein | 4 | 0 | 0 | 4 |
ATP-dependent phosphofructokinase | 5 | 0 | 0 | 5 |
Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
NFKB1 protein, partial | 3 | 0 | 0 | 3 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
regulator of G-protein signaling 4 | 6 | 0 | 0 | 6 |
muscarinic acetylcholine receptor M1 | 6 | 0 | 0 | 6 |
Alpha-2A adrenergic receptor | 0 | 6 | 3 | 9 |
Alpha-2B adrenergic receptor | 0 | 4 | 2 | 6 |
Alpha-2C adrenergic receptor | 0 | 6 | 3 | 9 |
Alpha-2B adrenergic receptor | 0 | 6 | 1 | 7 |
Alpha-1D adrenergic receptor | 0 | 5 | 3 | 8 |
Adenosine receptor A2b | 0 | 0 | 2 | 2 |
Adenosine receptor A2a | 0 | 1 | 2 | 3 |
Alpha-1A adrenergic receptor | 0 | 5 | 5 | 10 |
Alpha-1B adrenergic receptor | 0 | 5 | 5 | 10 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 7 | 0 | 0 | 7 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 4 | 0 | 0 | 4 |
Chain A, Ferritin light chain | 4 | 0 | 0 | 4 |
interleukin 8 | 1 | 0 | 0 | 1 |
acetylcholinesterase | 6 | 0 | 0 | 6 |
phosphopantetheinyl transferase | 3 | 0 | 0 | 3 |
SMAD family member 2 | 4 | 0 | 0 | 4 |
ATAD5 protein, partial | 2 | 0 | 0 | 2 |
Fumarate hydratase | 2 | 0 | 0 | 2 |
SMAD family member 3 | 4 | 0 | 0 | 4 |
TDP1 protein | 8 | 0 | 0 | 8 |
Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 3 | 4 | 0 | 0 | 4 |
EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
glucocorticoid receptor [Homo sapiens] | 8 | 0 | 0 | 8 |
estrogen-related nuclear receptor alpha | 10 | 0 | 0 | 10 |
farnesoid X nuclear receptor | 4 | 0 | 0 | 4 |
pregnane X nuclear receptor | 7 | 0 | 0 | 7 |
G | 3 | 0 | 0 | 3 |
polyprotein | 2 | 0 | 0 | 2 |
P53 | 1 | 0 | 0 | 1 |
peroxisome proliferator activated receptor gamma | 5 | 0 | 0 | 5 |
arylsulfatase A | 5 | 0 | 0 | 5 |
IDH1 | 4 | 0 | 0 | 4 |
euchromatic histone-lysine N-methyltransferase 2 | 11 | 0 | 0 | 11 |
aryl hydrocarbon receptor | 6 | 0 | 0 | 6 |
thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
Bloom syndrome protein isoform 1 | 4 | 0 | 0 | 4 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
hemoglobin subunit beta | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 6 | 0 | 0 | 6 |
DNA polymerase iota isoform a (long) | 3 | 0 | 0 | 3 |
geminin | 6 | 0 | 0 | 6 |
peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 3 | 0 | 0 | 3 |
M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
muscleblind-like protein 1 isoform 1 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit pi | 3 | 0 | 0 | 3 |
ATP-binding cassette sub-family C member 3 | 0 | 4 | 0 | 4 |
Multidrug resistance-associated protein 4 | 0 | 4 | 0 | 4 |
Bile salt export pump | 0 | 2 | 0 | 2 |
Bile salt export pump | 0 | 9 | 0 | 9 |
Interferon beta | 4 | 0 | 0 | 4 |
HLA class I histocompatibility antigen, B alpha chain | 3 | 0 | 0 | 3 |
Cellular tumor antigen p53 | 8 | 0 | 0 | 8 |
Gamma-aminobutyric acid receptor subunit beta-1 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit delta | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 3 | 0 | 0 | 3 |
Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-3 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-2 | 3 | 0 | 0 | 3 |
GABA theta subunit | 3 | 0 | 0 | 3 |
Inositol hexakisphosphate kinase 1 | 3 | 0 | 0 | 3 |
Canalicular multispecific organic anion transporter 1 | 0 | 4 | 0 | 4 |
ATPase family AAA domain-containing protein 5 | 4 | 0 | 0 | 4 |
Ataxin-2 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit epsilon | 3 | 0 | 0 | 3 |
Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 3 | 0 | 0 | 3 |
USP1 protein, partial | 2 | 0 | 0 | 2 |
chromobox protein homolog 1 | 5 | 0 | 0 | 5 |
flap endonuclease 1 | 2 | 0 | 0 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 4 | 1 | 5 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M1 | 0 | 3 | 2 | 5 |
Muscarinic acetylcholine receptor M3 | 0 | 3 | 0 | 3 |
Chain A, Cruzipain | 1 | 0 | 0 | 1 |
cytochrome P450 2D6 | 5 | 0 | 0 | 5 |
Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-1B adrenergic receptor | 0 | 0 | 2 | 2 |
cytochrome P450 2C9 precursor | 2 | 0 | 0 | 2 |
Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 3 | 0 | 5 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 3 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 2 | 2 | 4 |
D | 0 | 2 | 0 | 2 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 3 | 1 | 4 |
Amine oxidase [flavin-containing] A | 0 | 2 | 0 | 3 |
Alpha-2C adrenergic receptor | 0 | 4 | 1 | 5 |
Alpha-2A adrenergic receptor | 0 | 4 | 1 | 5 |
Alpha-1D adrenergic receptor | 0 | 3 | 0 | 3 |
D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 3 | 1 | 4 |
Alpha-2B adrenergic receptor | 0 | 0 | 0 | 2 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 3 | 1 | 4 |
Histamine H2 receptor | 3 | 0 | 0 | 3 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 0 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 0 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Nischarin | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
Nischarin | 0 | 1 | 0 | 1 |
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
Chain H, Fab M82G2, Heavy chain | 0 | 0 | 1 | 1 |
Chain L, Fab M82G2, Light chain | 0 | 0 | 1 | 1 |
Chain H, Fab M82g2, Heavy Chain | 0 | 0 | 1 | 1 |
Chain L, Fab M82g2, Light Chain | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, heart | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 3 | 0 | 4 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 1 | 3 |
Tryptophan 5-hydroxylase 1 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 3 | 0 | 3 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 1F | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 6 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 3 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 5B | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 1 | 2 |
Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 3 | 0 | 3 |
Leukotriene B4 receptor 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 5 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 1 | 2 |
Leukotriene B4 receptor 2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Transporter | 0 | 2 | 0 | 2 |
Chain A, Beta-lactamase | 4 | 0 | 0 | 4 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
Genome polyprotein | 0 | 1 | 1 | 2 |
Luciferase | 3 | 0 | 0 | 3 |
chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 5 | 0 | 0 | 5 |
bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 6 | 0 | 0 | 6 |
thyrotropin-releasing hormone receptor | 3 | 0 | 0 | 3 |
vitamin D3 receptor isoform VDRA | 4 | 0 | 0 | 4 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 2 | 0 | 0 | 2 |
DNA polymerase kappa isoform 1 | 3 | 0 | 0 | 3 |
relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
large T antigen | 0 | 1 | 0 | 1 |
estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
progesterone receptor | 6 | 0 | 0 | 6 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
Chain A, probable fosfomycin resistance protein | 0 | 0 | 1 | 1 |
Chain B, probable fosfomycin resistance protein | 0 | 0 | 1 | 1 |
Carbonic anhydrase 1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
DNA polymerase catalytic subunit | 0 | 1 | 0 | 1 |
DNA polymerase catalytic subunit | 0 | 1 | 0 | 1 |
DNA polymerase alpha catalytic subunit | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
DNA polymerase delta catalytic subunit | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 1 | 1 | 2 |
nonstructural protein 1 | 3 | 0 | 0 | 3 |
67.9K protein | 1 | 0 | 0 | 1 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
Acid-sensing ion channel 3 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
Albumin | 0 | 1 | 1 | 2 |
Albumin | 0 | 1 | 0 | 1 |
Albumin | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Cholinesterase | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 3 | 0 | 3 |
Fatty acid-binding protein, intestinal | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 1 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Caspase-1 | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
Caspase-3 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
Caspase-4 | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
Caspase-5 | 0 | 1 | 0 | 1 |
Caspase-9 | 0 | 1 | 0 | 1 |
Acid-sensing ion channel 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
Potassium channel subfamily K member 3 | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 9 subunit alpha | 0 | 3 | 0 | 3 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
glp-1 receptor, partial | 3 | 0 | 0 | 3 |
GALC protein | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 4 | 0 | 0 | 4 |
galanin receptor type 3 | 0 | 1 | 0 | 1 |
PPM1D protein | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Glucocorticoid receptor | 0 | 6 | 2 | 13 |
Glycine receptor subunit alpha-1 | 0 | 6 | 0 | 6 |
Androgen receptor | 0 | 3 | 0 | 3 |
Glycine receptor subunit beta | 0 | 6 | 0 | 6 |
Glycine receptor subunit alpha-2 | 0 | 6 | 0 | 6 |
Glycine receptor subunit alpha-3 | 0 | 6 | 0 | 6 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 0 | 1 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 1 | 2 |
Delta-type opioid receptor | 0 | 0 | 1 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 2 |
Kappa-type opioid receptor | 0 | 0 | 1 | 1 |
Mu-type opioid receptor | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
streptokinase A precursor | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase 1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase OXA-10 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Beta-lactamase TEM | 0 | 1 | 0 | 2 |
Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Efflux transporter | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase Toho-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Class D beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-b-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase IMP-1 | 0 | 0 | 0 | 1 |
BlaVIM-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 1 |
Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
Beta-lactamase VIM-1 | 0 | 0 | 0 | 1 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 3 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 3 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 3 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 3 |
Cytochrome P450 2A6 | 0 | 1 | 1 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor DM1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
luciferase | 0 | 0 | 0 | 1 |
Estrogen receptor | 0 | 2 | 0 | 2 |
Progesterone receptor | 0 | 2 | 0 | 3 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
Androgen receptor | 0 | 2 | 0 | 2 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Histamine H1 receptor | 0 | 0 | 1 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 2 | 0 | 2 |
pregnane X receptor | 2 | 0 | 0 | 2 |
nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 1 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
endonuclease IV | 1 | 0 | 0 | 1 |
alpha-galactosidase | 1 | 0 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
cGMP-gated cation channel alpha-1 | 0 | 0 | 1 | 1 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
guanine nucleotide-binding protein subunit alpha-15 | 0 | 1 | 1 | 2 |
D(3) dopamine receptor isoform e | 1 | 0 | 0 | 1 |
trace amine-associated receptor 1 | 0 | 1 | 1 | 2 |
Polyphenol oxidase 2 | 0 | 0 | 0 | 1 |
Phenylethanolamine N-methyltransferase | 0 | 1 | 0 | 1 |
Dopamine beta-hydroxylase | 0 | 0 | 0 | 1 |
D(1A) dopamine receptor | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
Beta-secretase 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Histamine H3 receptor | 0 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |